Ascentage Pharma Group International (AAPG) Enterprise Value: 2022-2025
- Ascentage Pharma Group International's Enterprise Value was N/A to $3.4 billion in Q2 2025 from the same period last year, while for Jun 2025 it was $3.4 billion, marking a year-over-year change of. This contributed to the annual value of -$122.4 million for FY2024, which is 13.96% up from last year.
- According to the latest figures from Q2 2025, Ascentage Pharma Group International's Enterprise Value is $3.4 billion, which was up 2,901.91% from -$122.4 million recorded in Q4 2024.
- Ascentage Pharma Group International's 5-year Enterprise Value high stood at $3.4 billion for Q2 2025, and its period low was -$189.2 million during Q4 2022.
- Its 3-year average for Enterprise Value is $1.1 billion, with a median of -$122.4 million in 2024.
- Data for Ascentage Pharma Group International's Enterprise Value shows a peak YoY increased of 23.80% (in 2023) over the last 5 years.
- Ascentage Pharma Group International's Enterprise Value (Quarterly) stood at -$189.2 million in 2022, then climbed by 23.80% to -$144.2 million in 2023, then rose by 15.13% to -$122.4 million in 2024, then reached $3.4 billion in 2025.
- Its last three reported values are $3.4 billion in Q2 2025, -$122.4 million for Q4 2024, and -$144.2 million during Q4 2023.
